T1	Outcomes 734 809	change from baseline at day 15 in the patient-assessed shoulder pain score.
T2	Outcomes 848 1040	investigator-assessed shoulder function, patient-assessed quality of life on the Short-Form-36 (SF-36) Acute Health Survey and both patients' and investigators' overall assessment of efficacy.
T3	Outcomes 1080 1099	shoulder pain score
T4	Outcomes 1217 1227	difference
T5	Outcomes 1371 1410	Investigator-assessed shoulder function
T6	Outcomes 1493 1541	Quality of life as measured by SF-36 total score
T7	Outcomes 1695 1701	effect
T8	Outcomes 1709 1735	SF-36 'mental health' item
T9	Outcomes 2003 2011	efficacy
T10	Outcomes 2144 2158	adverse events
T11	Outcomes 2429 2465	patient-assessed shoulder pain score
T12	Outcomes 2628 2645	shoulder function
T13	Outcomes 2830 2845	quality of life
T14	Outcomes 2895 2915	tolerability results
